4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001562180-25-004681
CFO AND TREASURER sold 12,000 shares at an average $325.37 ($3,904,496)
- CFO AND TREASURER acquired 12,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
EDGEMOND JAMES · CFO AND TREASURER
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-06-09 | Exercise or conversion : show line 1 in the form 10b5-1 | +12,000 | $117.76 | $1,413,120 | 20,118 | D |
| 2025-06-09 | Sale : show line 2 in the form 10b5-1 | −3,595 | $325.44 | $1,169,955 | 16,523 | D |
| 2025-06-09 | Sale : show line 3 in the form 10b5-1 | −305 | $326.56 | $99,602 | 16,218 | D |
| 2025-06-09 | Sale : show line 4 in the form 10b5-1 | −100 | $328.28 | $32,828 | 16,118 | D |
| 2025-06-09 | Sale : show line 5 in the form 10b5-1 | −7,700 | $325.20 | $2,504,068 | 8,418 | D |
| 2025-06-09 | Sale : show line 6 in the form 10b5-1 | −300 | $326.81 | $98,042 | 8,118 | D |
| Open-market sales · 12,000 sh · avg $325.37 · $3,904,496 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2025-06-09 | Exercise or conversion : show line 7 in the form 10b5-1 Stock Option | −12,000 | $117.76 | 2027-03-15 | 12,000 | 87,500 | D |
Loading xslF345X05/primarydocument.xml…